Abstract:Aging is known to contribute to the development of endothelial dysfunction and as such facilitates the development of cardiovascular diseases (CVD). The loss of the ability of endothelial cells to produce physiological amounts of nitric oxide (NO) partly underlies the detrimental effects of aging. Thus, the identification of agents that can mitigate aging induces loss of endothelial cell function (i.e. NO production) are of great interest. Several reports indicate that the administration of the cacao flavanol (−)‐epicatechin (Epi), can partly reverse the deleterious effects of aging in organs such as the heart and kidneys. However, less is known on its effect on aged endothelium. To address this question, we implemented a primary cell model of aging that is based on the use of high passage number (31–35) bovine coronary endothelial cells (BCAEC) in culture. We specifically evaluated NO production through the endothelial NO synthase (NOS) pathway, markers of cell senescence (β‐galactosidase) and mitochondrial biogenesis (sirtuin‐1, mitofilin, oxidative phosphorylation complexes II, IV and V, Tfam and citrate synthase activity). BCAEC at low passage number (8–13 passage number) were used as “young” controls. Cells were treated with either vehicle (water) of Epi (100 nM) for 48 h and media and cells collected for testing using kits (NO, citrate synthase) or Western blots. All experiments were performed independently a minimum of 3 times in triplicate. All results were statistically analyzed. Results indicate that senile cells loose their capacity to produce NO by ~33% (p<0.05) and that Epi treatment can essentially fully restore their production levels to those noted for vehicle treated young cells. These results paralleled to those noted for the phosphorylation of eNOS. While β‐galactosidase levels doubled (100% increase) in aged cells, those treated with Epi only evidenced about a 40% increase (p<0.05). The levels of phosphorylated sirtuin‐1, mitofilin, oxidative phosphorylation complexes and Tfam were all reduced by ~40% with aging (p<0.05) and were largely restored by Epi treatment. Altogether, results strongly suggest that Epi can partly reverse markers of endothelial cell aging by restoring critical components of vascular function. These effects may partly explain the epidemiological evidence for the beneficial effects of cocoa consumption on the incidence of CVD. Support or Funding Information NIH DK98717

eNOS-dependent antisenscence effect of a calcium channel blocker in human endothelial cells

Endothelial cellular senescence is inhibited by nitric oxide: Implications in atherosclerosis associated with menopause and diabetes

Autophagy protects against senescence and apoptosis via the RAS-mitochondria in high-glucose-induced endothelial cells.

GW24-e3737 MicroRNA-210 mediates the protective effect of nitrate on endothelial progenitor cells against senescence induced by angiotensin II through suppressing gene SCH9

Nintedanib ameliorates oxidized low-density lipoprotein -induced inflammation and cellular senescence in vascular endothelial cells

Replicative Endothelial Cell Senescence May Lead to Endothelial Dysfunction by Increasing the BH2/BH4 Ratio Induced by Oxidative Stress, Reducing BH4 Availability, and Decreasing the Expression of eNOS

Nicotinamide Mononucleotide Alleviates Angiotensin II-Induced Human Aortic Smooth Muscle Cell Senescence in a Microphysiological Model.

Caloric restriction suppresses endothelial cells senescence via down-regulation of NOX4 induced by HNF3γ]

Chronic treatment with N-acetyl-cystein delays cellular senescence in endothelial cells isolated from a subgroup of atherosclerotic patients

Chronological attenuation of NPRA/PKG/AMPK signaling promotes vascular aging and elevates blood pressure

NRF2-HIF2α Signaling Attenuates Endothelial Cell Senescence and Maintains Intercellular Junctions in Diabetes

Heme oxygenase-1 ameliorates oxidative stress-induced endothelial senescence via regulating endothelial nitric oxide synthase activation and coupling

Correlation of different NADPH oxidase homologues with late endothelial progenitor cell senescence induced by angiotensin II: effect of telmisartan

Effect of telmisartan on nitric oxide--asymmetrical dimethylarginine system: role of angiotensin II type 1 receptor gamma and peroxisome proliferator activated receptor gamma signaling during endothelial aging

Beneficial Effects of (−)‐Epicatechin on Biomarkers of Endothelial Cell Aging

Induction of endothelial nitric oxide synthase, SIRT1, and catalase by statins inhibits endothelial senescence through the Akt pathway

Advanced glycation end-products decreases expression of endothelial nitric oxide synthase through oxidative stress in human coronary artery endothelial cells

Prevention and reversal of premature endothelial cell senescence and vasculopathy in obesity-induced diabetes by ebselen

Long-term stimulation of angiotensin II induced endothelial senescence and dysfunction

Endothelial Nitric Oxide Synthase Enhancer AVE3085 Reverses Endothelial Dysfunction Induced by Homocysteine in Human Internal Mammary Arteries

Mechanism of Reversal of High Glucose-Induced Endothelial Nitric Oxide Synthase Uncoupling by Tanshinone IIA in Human Endothelial Cell Line EA.hy926.